Event Report 2023
-
ICH Project
The 5th ICH Forum: ICH Quality Guideline Update
-
International Affairs Committee
The 4th Japan-Vietnam Joint Symposium" will be held
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2023" will be held
-
Secretariat
The 22nd JPMA Forum" was held.
-
Drug Evaluation Committee
Assembly of the Drug Evaluation Committee for FY 2023
Breakthrough to Drug Loss - Aiming to Realize Safe, Secure, and Well-Being Medicine and Society -
International Affairs Committee
Joint Conference on Global Health 2023" was held.
Co-sponsored Symposium on "Drug Resistance (AMR) as a Global Health Challenge. -
Public Affairs Committee
The 40th Public Relations Seminar
-Social networking and web literacy seminar -
International Affairs Committee
The "Regular Meeting with the French Association of the Pharmaceutical Industry (Leem)" was held
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
ICH Project
ICH Prague Meeting" was held
-
Drug Evaluation Committee
Workshop on "Next Generation Adverse Reaction Case Evaluation" was held.
-
International Affairs Committee
Special Session Held at the 10th Nikkei-FT Conference on Infectious Diseases
Toward the Creation of a Drug Discovery Ecosystem in the Infectious Disease Field: A Year in Review and Future Initiatives -
Review Board of Ethical Drug Product Information Brochure
Briefing on the Revision of the "Guidelines for the Preparation of Product Information Summaries, etc. for Ethical Drugs" Held
-
Biopharmaceutical Committee
Report on "BioJapan 2023
Opening Ceremony and Keynote Speech, Biopharmaceutical Committee Seminar -
International Affairs Committee
The 11th Japan-Taiwan Pharmaceutical Exchange Conference" was held.
-
Pharmaceutical Industrial Policy Committee
Seminar on Economic Security and Cyber Security" was held
-
Code Compliance Committee
Meeting of Code Administration Managers and Practitioners for FY2023
-
International Affairs Committee
JPMA Aging Group and HGPI Joint Symposium Held
Health Challenges Associated with Aging, Dementia and Cancer - Early Initiatives to Extend Healthy Life Expectancy -
Regulatory Affairs Committee
The 13th Annual Conference of the Regulatory Science Society of Japan" was held
Progress and Harmonization Required in Regulatory Science -
Quality & Technology Committee
The 50th GMP Case Study Workshop in FY 2023 (the 50th)" was held
-
APAC Project
APEC Good Registration Management (GRM),Center of Excellence (CoE) Workshop 2023" was held.
First local workshop held after the COVID-19 pandemic -
International Affairs Committee
The 5th Japan-Korea Symposium on Regulation of Medical Products
-
The Office of Pharmaceutical Industry Research
Forum on "The Value of Drugs and DTx for the Public" hosted by the Institute for Policy Studies
-
Public Affairs Committee
The 39th Public Relations Seminar" Held
-What was discussed at the Expert Panel Meeting? -
International Affairs Committee
Opinion Exchange Meeting with Mr. Dao Hong Lan, Minister of Health of Vietnam" was held.
-
International Affairs Committee
JPMA Media Forum" Held
Action Plan for Combating Drug Resistance (AMR) 2023-2027 - Key Points and Future Responses -
Pharmaceutical Industrial Policy Committee
Economic Security Seminar "Economic Security and the Pharmaceutical Industry
-
ICH Project
ICH Vancouver Meeting" was held
-
Public Affairs Committee
JPMA Presidents Press Conference
Hiroaki Ueno, New President, Delivers a Statement of Position -
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Health and Economy "The World's Focus: The Future of Health Economics Research in Japan's Aging Society" -
Consumer Consultation Review Committee
Assembly of the Consumer Consultation Review Committee for FY2023
-
International Affairs Committee
Joint Symposium with the Joint Annual Meeting of the Japanese Society of Infectious Diseases and the Japanese Society of Chemotherapy
Bringing antimicrobials from Japan back to the world! Building a Drug Discovery Ecosystem through Industry-Academia-Government Collaboration -
Regulatory Affairs Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee for FY2023
-
APAC Project
The 12th Asian Pharmaceutical Association Collaboration Conference (APAC)
-Delivering Innovative Medicines to the People of Asia Promptly -
Biopharmaceutical Committee
JPMA Media Forum" Held
What to do about Vaccines? -What we can do now for the future -
Public Affairs Committee
The 34th JPMA Policy Seminar" Held
Toward Revival of Japan's Innovation Creation Potential: Will the Healthcare Ecosystem Lead to Japan's Reinvigoration? -
Code Compliance Committee
Meeting of Compliance Managers and Practitioners for Fiscal Year 2022
-
Public Affairs Committee
JPMA Media Forum" Held
-The current trend of science, technology and innovation from a bird's eye view of the life science field and its implications for the drug discovery field -
Public Affairs Committee
JPMA Presidents Press Conference
Business Model of the Pharmaceutical Industry and Pharmaceutical Industry Policy and Recommendations 2023 -
Intellectual Property Committee
Held the "2023 Life Science IP Forum
-Current Status, Prospects and Challenges of Digital Therapeutics (DTx) -
International Affairs Committee
The 6th Japan-India Symposium on Regulation of Medical Products
-
International Affairs Committee
The 9th Japan-Thailand Joint Symposium" will be held
-
Public Affairs Committee
The 34th JPMA Policy Seminar" Held
Toward Revival of Japan's Innovation Creation Potential: Will the Healthcare Ecosystem Lead to Japan's Reinvigoration?